How is one of the world’s largest pharmaceutical companies promoting sustainability and regulatory compliance throughout its ...
Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and ...
Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...
18h
Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...
From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.
Following the report, several state legislators – including Carr, K.C. Ohaebosim, Henry Helgerson, Susan Estes, Angela ...
Loblaw divests 42 Wellwise by Shoppers stores to Verillium Health Care, focusing on pharmacy growth as the healthcare brand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback